EQS-News: Bank of America Securities Europe SA: Exercise of the Greenshoe Option and Post-stabilisation Period Announcement
Werte in diesem Artikel
|
EQS-News: Bank of America Securities Europe SA
/ Key word(s): IPO
Werbung
6 October 2023
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
SCHOTT Pharma AG & Co. KGaA
Exercise of the Greenshoe Option and Post-stabilisation Period Announcement
Further to the pre-stabilisation period announcement dated 27 September 2023, BofA Securities Europe SA (contact: Victor Dumas Vorzet; telephone: +33187701048) hereby gives notice that the Stabilisation Manager named below has fully exercised the over-allotment/greenshoe option (of up to 4,518,438 shares) on 6 October 2023 in respect of 4,518,438 shares at the offer price of EUR 27.00 per share and that the stabilisation period has been concluded early on 6 October 2023. During the stabilisation period, the Stabilisation Manager did not undertake stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/2016/2014), and also as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) in relation to the offer of the following securities, as set out below. Werbung
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction. This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States. Werbung
06.10.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
1742835 06.10.2023 CET/CEST
Ausgewählte Hebelprodukte auf SCHOTT Pharma
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf SCHOTT Pharma
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle SCHOTT Pharma Aktie News
SCHOTT Pharma Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für SCHOTT Pharma nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08:41 | SCHOTT Pharma Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.07.26 | SCHOTT Pharma Kaufen | DZ BANK | |
| 09.07.26 | SCHOTT Pharma Buy | Deutsche Bank AG | |
| 09.07.26 | SCHOTT Pharma Hold | Jefferies & Company Inc. | |
| 09.07.26 | SCHOTT Pharma Outperform | RBC Capital Markets |
